Research study Program year 2020 Source: CMS Open Payments

Menb Rec 2Nd Gen-045 (V72_79)

Research payments

$111,010

37 payments

Through program year 2020, $111,010 in research payments was reported against Menb Rec 2Nd Gen-045 (V72_79), across 37 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2020	Research	$111,010	37

Breakdown

Who paid Research payments · program year 2020

GlaxoSmithKline, LLC. $111,010 37 payments

Who received the money Research payments · program year 2020

Square One Clinical Research Organisation paid for research $45,482 16 payments
Blue Grass Clinical Research INC Organisation paid for research $41,029 14 payments
Velocity Clinical Research Organisation paid for research $13,000 4 payments
Benchmark Research Organisation paid for research $6,500 2 payments
Jbr Clinical Research Organisation paid for research $5,000 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.